CardIQ Suite vs Tempus ECG-Low EF
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
CardIQ Suite focuses on comprehensive cardiac CT post-processing, offering automated calcium scoring and CCTA review for detailed cardiovascular disease diagnosis and treatment planning. Tempus ECG-Low EF, on the other hand, is an AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction, primarily aiding in identifying patients at risk of heart failure. While both are cardiology AI tools, CardIQ Suite provides detailed anatomical and plaque analysis from CT scans, whereas Tempus ECG-Low EF offers a screening tool for heart failure risk based on ECG data.
Choose CardIQ Suite if…
Choose CardIQ Suite if your primary need is comprehensive, automated post-processing and review of cardiac CT scans. This tool excels in detailed anatomical analysis, including calcium scoring, CCTA review with cine capabilities, and plaque burden quantification, making it ideal for in-depth cardiovascular disease diagnosis and treatment planning.
View CardIQ Suite →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your focus is on rapidly identifying patients at risk of heart failure through the analysis of standard 12-lead ECG recordings. This AI software provides a quick binary output for low LVEF, serving as an effective screening tool to flag patients 40 years or older who may require further cardiac evaluation.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CardIQ Suite | Tempus ECG-Low EF |
|---|---|---|
| Pricing | Unknown | Contact vendor |
| Deployment | On-premise (integrated with CT systems) | Software, integrated into healthcare facility workflows |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CardIQ Suite | Tempus ECG-Low EF |
|---|---|---|
| Name | CardIQ Suite | Tempus ECG-Low EF |
| Company | GE Medical Systems SCS | Tempus AI |
| Description | CardIQ Suite is an AI-powered cardiac CT post-processing application by GE Medical Systems SCS, offering automated calcium scoring and CCTA review for comprehensive cardiovascular disease diagnosis and treatment planning. | Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
| Key Features | Deep Learning based automated Calcium Score and labeling of coronary artery territories; Integrated workflow for seamless review of calcium scoring and CCTA data; CCTA 2D Review with cine capability for motion studies and chamber mobility analysis; Double oblique tools for detailed visualization of coronary vasculature; Measurement tools for distance and Region of Interest (ROI) generation; Ability to assign calcifications to individual coronary artery branches; Ability to score and label calcifications found in the aorta and cardiac valves; Plaque ID tool for visualizing and quantifying plaque burden (CardIQ Xpress 2.0 Reveal) | AI-powered algorithm for ECG analysis; Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%); Analyzes resting, non-ambulatory 12-lead ECG recordings; Provides a binary output (Low LVEF Detected / Not Detected); Aids in identifying patients 40+ years at risk of heart failure; Trained on a large dataset of over 930,000 ECGs from 170,000+ patients; Intended for use in clinical diagnostic settings at healthcare facilities |
Videos
Demos, reviews, and walkthroughs featuring CardIQ Suite and Tempus ECG-Low EF.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
CardIQ Suite offers an integrated workflow for seamless review of calcium scoring and CCTA data, allowing for easy transition between these tasks. Tempus ECG-Low EF is designed to work with existing ECG platforms and EHRs, enabling AI insights within clinical workflows and employing EHR integrations to filter eligible patients.
CardIQ Suite demonstrates high consistency and identification rates for coronary artery calcifications, with over 90% concordance with CACS-DRS classification and over 95% correct identification of calcifications. Tempus ECG-Low EF has a sensitivity of 86% and specificity of 83% for classifying patients with low LVEF, with a negative predictive value of 98%.
While specific details on the learning curve for CardIQ Suite are not provided, its 'built for automation and workflow efficiency' tagline suggests ease of use. Tempus ECG-Low EF is intended to be interpreted in conjunction with other diagnostic information, implying a need for clinical judgment alongside the AI output. Tempus emphasizes providing AI-enabled precision medicine solutions to physicians.
CardIQ Suite is a comprehensive post-processing application for cardiac CT, aiding in the diagnosis and treatment planning for coronary artery disease and myocardial function through automated calcium scoring and CCTA review. Tempus ECG-Low EF analyzes 12-lead ECGs to detect signs of low LVEF in patients 40 years or older at risk of heart failure, serving as an aid for further evaluation rather than a standalone diagnostic tool.
While specific audit-trail features for CardIQ Suite are not detailed, GE Healthcare's quality system ensures design control testing and compliance with regulations. Tempus emphasizes its commitment to patient privacy and data security through a multilayered approach, including strict access controls and regular third-party audits, which would typically include audit-trail functionalities.
CardIQ Suite is deployed on-premise via GE Advantage Workstation, which may require specific hardware and infrastructure considerations for multi-site deployment. Tempus ECG-Low EF is deployed as software integrated into healthcare facility workflows, suggesting a potentially more flexible rollout across various sites, especially with its EHR integration capabilities.
More Comparisons
More matchups featuring CardIQ Suite or Tempus ECG-Low EF
Backers
Who funded each tool's parent company.